Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary Strictures
Status: | Recruiting |
---|---|
Conditions: | Liver Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 9/13/2018 |
Start Date: | July 29, 2017 |
End Date: | July 1, 2020 |
Contact: | Subhas Banerjee, MD |
Email: | sbanerje@stanford.edu |
Phone: | 650-723-2623 |
Comparative Efficacy of Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies for Obtaining Diagnostic Tissue From Indeterminate Biliary Strictures
Prospective, randomized, multi-center study. Investigators will compare diagnostic yield of
bile duct brushings, pediatric biopsy forceps biopsies and cholangioscopy-directed biopsies
for obtaining diagnostic tissue from biliary strictures.
bile duct brushings, pediatric biopsy forceps biopsies and cholangioscopy-directed biopsies
for obtaining diagnostic tissue from biliary strictures.
Inclusion Criteria:
1. All patients with obstructive jaundice, and imaging (CT or MRI) suggestive of biliary
stricture, without obvious pancreatic mass
2. All patients with obstructive jaundice, and index ERCP suggestive of biliary
stricture, without obvious pancreatic mass
3. All patients with obstructive jaundice, and prior ERCP suggestive of biliary stricture
4. Expected patient survival of at least 90 days
5. High likelihood of patient follow-up
6. Patient is able to give a written informed consent
7. Patient is willing and able to comply with the study procedures
Exclusion Criteria:
1. Patients with imaging suggestive of pancreatic tumor
2. Children < 18 years of age
3. Pregnant women
4. Patients with impaired decision-making
5. Healthy volunteers
6. Primary Sclerosing Cholangitis (PSC)
7. Patients with untreated coagulopathy at the time of procedure or ongoing need for
anti-coagulation
8. Patients with any contraindication to endoscopic procedure
9. Participation in another investigational study that may directly or indirectly affect
the results of this study within 30 days prior to the initial visit
10. Patients unable to provide informed consent
We found this trial at
1
site
300 Pasteur Dr
Stanford, California 94305
Stanford, California 94305
(650) 723-4000
Principal Investigator: Subhas Banerjee, MD
Stanford Univ Med Ctr The Medical Center is uniquely advantaged by its location on the...
Click here to add this to my saved trials